Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Prevention of Vancomycin-Induced Nephrotoxicity; an Updated Review of Clinical and Preclinical Studies Publisher Pubmed



Rahmani H1 ; Khalili H1
Authors

Source: Infectious Disorders - Drug Targets Published:2022


Abstract

Purpose: This paper aims to review clinical and preclinical evidence regarding new strategies for the prevention of vancomycin-induced nephrotoxicity. Methods: Evidence from 2014 to the end of 2019 was included. Twelve animal studies and one clinical trial were evaluated. Results: Although the incidence of vancomycin-induced nephrotoxicity was not reduced significantly in the clinical trial, antioxidants reduced the incidence of vancomycin-induced nephrotoxicity in preclinical studies. Conclusion: Antioxidants including vitamin C, vitamin E, cilastatin, melatonin, zingerone, rutin, naringenin, saffron, silymarin, and dexmedetomidine were nephroprotective against vancomycininduced nephrotoxicity in preclinical studies. The nephroprotective effects of these antioxidants must be confirmed before routine use in clinical practice. © 2022 Bentham Science Publishers.
Other Related Docs
7. Reappraisal of Nonsteroidal Anti-Inflammatory Drugs̕ Effects on Kidney Outcomes, Palestinian Medical and Pharmaceutical Journal (2022)
11. An Update on Allopurinol and Kidney Failure; New Trend for an Old Drug, Journal of Renal Injury Prevention (2017)